Are third-generation cephalosporins still an option for empirical antibiotic therapy in critically ill trauma patients with early ventilator or hospital-acquired pneumonia?

Anaesth Crit Care Pain Med. 2021 Apr;40(2):100833. doi: 10.1016/j.accpm.2021.100833. Epub 2021 Mar 18.

Authors

Claire Oddos¹, Guillaume Bardonneau¹, Laurent Petit¹, Matthieu Biais², Cédric Carrie³

Affiliations

¹ Anaesthesiology and Critical Care Department, CHU Pellegrin, 33000 Bordeaux, France.
² Anaesthesiology and Critical Care Department, CHU Pellegrin, 33000 Bordeaux, France; Univ. Bordeaux Segalen, 33000 Bordeaux, France.
³ Anaesthesiology and Critical Care Department, CHU Pellegrin, 33000 Bordeaux, France. Electronic address: cedric.carrie@chu-bordeaux.fr.

PMID: 33746076
DOI: 10.1016/j.accpm.2021.100833

No abstract available

Keywords: Pneumonia; Third generation cephalosporins; Trauma.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / therapeutic use
Cephalosporins / therapeutic use
Critical Illness
Cross Infection* / drug therapy
Hospitals
Humans
Pneumonia* / drug therapy
Ventilators, Mechanical

Substances

Anti-Bacterial Agents
Cephalosporins